Feb. 12, 2026 7:35 PM ETBio-Rad Laboratories, Inc. (BIO) Stock, BIO.B StockAI-Generated Earnings Calls Insights ...
Good day, everyone, and welcome to the Bio-Rad Fourth Quarter and Full Year 2025 Results Conference Call. At this time, I would like to hand things over to Mr. Edward Chung. Please go ahead, sir. Good ...
Bio‑Rad ended 2025 with essentially flat sales (FY $2.583B; Q4 ~$693M) as Diagnostics growth offset Life Science softness, but margins were hit by execution‑related supply‑chain costs and portfolio ...
Bio-Rad Laboratories (BIO) came out with quarterly earnings of $2.51 per share, missing the Zacks Consensus Estimate of $2.57 per share. This compares to earnings of $2.9 per share a year ago. These ...
HERCULES, Calif. (AP) — HERCULES, Calif. (AP) — Bio-Rad Laboratories Inc. (BIO) on Thursday reported fourth-quarter net income of $720 million, after reporting a loss in the same period a year earlier ...
Bio-Rad Laboratories missed estimated earnings by -5.28%, reporting an EPS of $2.51 versus an estimate of $2.65. Revenue was up $25.70 million from the same period last year. In the previous quarter, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results